EURACTIV PR

An easy way of publishing your relevant EU press releases.

Publish a Press Release

Medicines for Europe

Press Releases of this organisation

TITLE ORGANISATION DATEsort descending TOPIC
Access to medicines critical in European Parliament vote on EU IP action plan Medicines for Europe Fri, 11/12/2021 Health & Consumers
Adjustments to IP framework needed to improve access to medicines in Europe Medicines for Europe Tue, 11/16/2021 Science & Policymaking
The EU must stop the offshoring of essential medicines manufacturing investments: ambitious, open and coherent policies must support competitive, robust and sustainable production of APIs and medicines Medicines for Europe Tue, 11/23/2021 Global Europe
European Parliament report calls for increased use of off-patent medicines to improve patient access Medicines for Europe Thu, 11/25/2021 Health & Consumers
Access to essential medicines threatened by combination of increasing inflation and potential further price cuts in EU countries Medicines for Europe Fri, 11/26/2021 Health & Consumers
Commission study highlights market framework conditions are main driver for medicines shortages Medicines for Europe Fri, 12/10/2021 Health & Consumers
Biosimilar medicines have delivered 18BN€ total savings for Europe but more action needed to translate this potential into patient access and sustainable health systems Medicines for Europe Thu, 12/16/2021 Health & Consumers
Stronger mandate for European Medicines Agency should prioritise patient access to medicines Medicines for Europe Mon, 01/24/2022 Health & Consumers
Regulatory reforms critical to improve patient access to medicines Medicines for Europe Mon, 01/24/2022 Health & Consumers
The European Commission needs to prioritise equitable access to biosimilar medicines in Europe Medicines for Europe Tue, 01/25/2022 Health & Consumers
Electronic product information: new report shows it is time to move from principles to action Medicines for Europe Fri, 02/25/2022 Health & Consumers
Repurposing: a golden opportunity for patient centric health investment in Europe Medicines for Europe Wed, 04/06/2022 Health & Consumers
Central & Eastern European patients have inequitable access to medicines for life-threatening conditions Medicines for Europe Mon, 04/25/2022 Health & Consumers
EU can do more for patients with smart use of biosimilar medicines Medicines for Europe Fri, 04/29/2022 Health & Consumers
Smart reform of EU pharma and IP legislation key to boosting access to essential medicines Medicines for Europe Thu, 06/30/2022 Health & Consumers
The off-patent medicines industry is a vital part of the solution for healthcare resilience Medicines for Europe Thu, 06/30/2022 Health & Consumers
Medicines for Europe warns strongly against energy rationing for medicines production Medicines for Europe Wed, 07/20/2022 Health & Consumers
EMA/HMA share definitive EU-wide position on biosimilar medicines interchangeability Medicines for Europe Tue, 09/20/2022 Health & Consumers
Energy Council (TTE) – Medicines for Europe Open letter to European Energy Ministers and responsible European Commissioners on inflation and energy costs impacting the supply of essential generic medicines Medicines for Europe Wed, 09/28/2022 Health & Consumers
Proposals on wastewater treatment will jeopardise patient access to medicines without helping green transition Medicines for Europe Thu, 10/27/2022 Health & Consumers
Pharmaceutical legislation reforms must support equitable access to medicine in Central and Eastern Europe and security of medicines supplies Medicines for Europe Thu, 11/17/2022 Health & Consumers
Giving medicines a new life: EU should foster patients’ access to Value Added Medicines Medicines for Europe Wed, 11/30/2022 Health & Consumers
2022 Health at a Glance Report highlights the need to rethink investments in health after the COVID-19 pandemic Medicines for Europe Mon, 12/05/2022 Health & Consumers
Billions more euros to re-invest in better healthcare thanks to biosimilar medicines Medicines for Europe Wed, 12/14/2022 Health & Consumers
EU can do more for equitable access to medicines Medicines for Europe Fri, 01/13/2023 Health & Consumers
Market reforms needed to secure essential antibiotics against AMR, report says Medicines for Europe Thu, 02/16/2023 Health & Consumers
Harmonised bioequivalence guideline paves the way for global generic medicine development and access to medicines Medicines for Europe Wed, 04/26/2023 Health & Consumers
Reaction to EU Pharmaceutical legislation: Timely and equitable access for patients and security of supply essential for reform Medicines for Europe Thu, 04/27/2023 Health & Consumers
Patients should benefit from greater access under new patent package proposals Medicines for Europe Fri, 04/28/2023 Health & Consumers
Future of pharmaceutical policy rests on secure supply of essential medicines Medicines for Europe Wed, 05/03/2023 Health & Consumers

Pages